All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â
Mimcipar 30mg Tablet
Prescription Required
Salt Composition : Cinacalcet
Manufacturer : MANKIND PHARMACEUTICALS LIMITED
Origin of Medicine : India
10 Tablet(s) In A Strip
Introduction to Mimcipar 30mg Tablet
Mimcipar 30mg Tablet is a calcimimetic medication containing the active ingredient Cinacalcet. This medication is used to treat hyperparathyroidism (overactivity of the parathyroid glands, which are small glands located in the neck) in patients with chronic kidney disease who are on dialysis. It is also used to treat hypercalcemia in patients with parathyroid carcinoma (a rare type of cancer that develops in the parathyroid glands). It helps regulate the levels of parathyroid hormone (PTH) in the body.
Before consuming this drug, inform your physician if you have had liver or heart failure or heart rhythm problems and have a history of seizures (fits or convulsions), as the risk of having seizures might be higher if you've experienced them. Mimcipar 30mg Tablet should not be taken by children under the age of 18 who have parathyroid cancer or primary hyperparathyroidism. This medication is not suitable for this age group for these conditions. If you are receiving treatment for secondary hyperparathyroidism, your doctor will carefully monitor your calcium levels before you start using the drug and throughout your treatment with the medication.
Mimcipar 30mg Tablet helps to reduce calcium levels in the body. However, in some cases, low calcium levels (hypocalcemia) have been reported in adults and children undergoing treatment. Therefore, you must inform your physician if you develop any indicative signs of low calcium levels, such as muscle spasms, twitches, cramps, numbness or tingling sensations in your extremities or around your mouth, and loss of consciousness while receiving this drug. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. It is unknown if this medicine passes into the breast milk. Please consult your doctor before breastfeeding.
Uses of Mimcipar 30mg Tablet
- Treatment of hyperparathyroidism
Therapeutic Effects of Mimcipar 30mg Tablet
Mimcipar 30mg Tablet works by increasing the sensitivity of the parathyroid gland to calcium, which reduces the release of parathyroid hormone. This helps to regulate calcium and phosphorus levels in the body.
Interaction of Mimcipar 30mg Tablet with other drugs
Inform your physician about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications such as ketoconazole, itraconazole, voriconazole, telithromycin, rifampicin, ciprofloxacin, ritonavir, and fluvoxamine may interact with Mimcipar 30mg Tablet and reduce effectiveness by causing undesirable side effects.
More Information about Mimcipar 30mg Tablet
- Store Mimcipar 30mg Tablet below 25°C.
- Protect from light and moisture.
How to consume Mimcipar 30mg Tablet
Take the Mimcipar 30mg Tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Safety Advices for Mimcipar 30mg Tablet
 Â
Pregnancy
 Â
If you are pregnant, suspecting, or planning for the pregnancy, report to your doctor before starting the treatment with Mimcipar 30mg Tablet.Â
 Â
Breast Feeding
 ÂIt is unknown whether Mimcipar 30mg Tablet is excreted in breast milk. If you are breastfeeding, consult to your doctor before starting the treatment with this drug.Â
 Â
Lungs
  It is unknown whether Mimcipar 30mg Tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.
 Â
Liver
  Mimcipar 30mg Tablet should be cautiously used in patients with severe liver diseases. Dose adjustments are necessary. Inform your doctor if you have liver issues before initiating the therapy.
 Â
Alcohol
 ÂIt is unknown whether consuming alcohol interacts with Mimcipar 30mg Tablet. Please consult your doctor for more advice.
 Â
Driving
 Â
Driving vehicles or operating machinery while taking Mimcipar 30mg Tablet is unsafe because in rare cases it may cause dizziness and seizures in some individuals.Â
Side Effects of Mimcipar 30mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Numbness and tingling around the mouth
- Muscle cramps
- Seizures
- Swelling of the face, lips, mouth, tongue or throat
- Difficulty swallowing or breathing
- Allergic reactions
Common
- Dizziness
- Loss of appetite
- Muscle pain
- Weakness
- Rash
- Low testosterone levels
- High potassium levels in the blood
- Upper respiratory infection
- Headache
- Low BP
- Cough
- Indigestion
- Diarrhea
- Stomach and back pain
- Constipation
Word of Advice
Mimcipar 30mg Tablet can cause stomach upset. To minimize this, your doctor may advise you to take the medication with food or antacids. Follow your doctor's recommendations on when and how to take the medication. Maintain proper hydration by drinking enough water throughout the day. Staying hydrated can help support your overall health and the effectiveness of your medications.
FAQs
Q 1. Who should not take Mimcipar 30mg Tablet?
Mimcipar 30mg Tablet may not be suitable for individuals with a history of hypocalcemia or hypersensitivity to the drug. It's important to consult a healthcare provider before starting the medication.
Q 2. Can Mimcipar 30mg Tablet cure hyperparathyroidism completely?
Mimcipar 30mg Tablet helps manage hyperparathyroidism by regulating parathyroid hormone (PTH) levels, but it may not necessarily cure the condition. It aims to improve abnormal hormone levels and associated complications.
Q 3. What are the common side effects of Mimcipar 30mg Tablet?
The common side effects of Mimcipar 30mg Tablet may include nausea, vomiting, diarrhea, loss of appetite, headache, and dizziness. More serious side effects, such as low calcium levels (hypocalcemia), can also occur.
Q 4. How is Mimcipar 30mg Tablet taken?
Mimcipar 30mg Tablet is usually taken orally in the form of tablets. The dosage and frequency will be determined by your physician based on your kidney function and response to treatment.
Q 5. What conditions is Mimcipar 30mg Tablet used to treat?
Mimcipar 30mg Tablet is primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis. It is also used to treat hypercalcemia in patients with parathyroid carcinoma.
Fact Box of Mimcipar 30mg Tablet
Molecule name: Cinacalcet | Therapeutic class: Calcimimetic agent |
Pharmacological class: Second-generation calcimimetics | Indications: Treatment of hyperparathyroidism |
References
- Amgen Ltd, Electronic Medicines Compendium (EMC), [Revised on Aug 2017] [Accessed on 29th August 2023, https://www.medicines.org.uk/emc/files/pil.11315.pdf
- KD Tripathi, Hormones and Drugs Affecting Calcium Balance, Essentials of Medical Pharmacology, 8th Edition, 2019, 360-372.
- Daniel D. Bickle, Agents that affect bone mineral homeostasis, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 772-791.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
4000+ products
We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.
Secure Payment
100% secure and trusted payment protection
Easy Return
We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.
